ArthroCare shares plummet to new low after accounting errors
This article was originally published in Clinica
Executive Summary
Shares in minimally-invasive surgical product manufacturer ArthroCare have dropped to their lowest ever price. This is perhaps unsurprising given that this week the firm announced the forthcoming restatement of its past sales over the last eight years, the resignation of two executive officers and the receipt of two subpoenas.